Asthma care in community health centers: a study by the southeast regional clinicians' network.
Federally funded community health centers (CHCs) were surveyed to assess their ability to serve low-income asthma patients in the southeastern United States. Data were collected on CHC clinicians, pharmacy services, and patient characteristics. Twenty-six (74%) of 35 participating CHCs provided data on 83 distinct clinic sites in eight states, representing 898,977 billable patient visits to 318,920 people during the one-year study period. Participating CHCs provided 23% of all CHC patient visits in Region IV in 1995. Sixty-two percent of patients had a family income below poverty level. Almost 75% of the patients were uninsured or receiving Medicaid. Asthma was the diagnosis code for 2.04% of all medical encounters. Twenty-nine percent of sites were unable to provide medications for uninsured asthma patients, while 66% could provide drug samples. Thirty-three percent of CHCs had in-house pharmacies and 33% offered pharmacy vouchers. Eighty-two percent could provide beta-agonist inhalers, 54% could provide steroid inhalers, and 17% could provide peak flow meters. Federally funded CHCs provide care to many asthma patients from the highest risk segments of the population, but often do not have the resources needed to follow current clinical guidelines.
Rust
G S
GS
National Center for Primary Care, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Murray
V
V
Octaviani
H
H
Schmidt
E D
ED
Howard
J P
JP
Anderson-Grant
V
V
Willard-Jelks
K
K
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000628:therapy*; D003153:Community Health Services / Q000706:statistics & numerical data; D005938:Glucocorticoids / Q000627:therapeutic use; D019538:Health Care Surveys; D006801:Humans; D007348:Insurance, Health; D009330:Nebulizers and Vaporizers; D011203:Poverty; D014481:United States
D000318:Adrenergic beta-Agonists; D005938:Glucocorticoids